The Board of Overseers is an advisory body committed to providing counsel and support to the ADDF Board of Governors and staff. Overseers lend their expertise to advance the ADDF's mission to accelerate the discovery of drugs to prevent, treat and cure Alzheimer’s disease. Overseers are appointed by and serve at the pleasure of the Board of Governors.

CO-CHAIRMEN

Sharon T. Sager, CIMA

Managing Director and Private Wealth Advisor, UBS Private Wealth Management

Randal Sandler

Director of Client Services and Marketing, Bridgewater Associates

Bio Bio

Carol Seabrook Boulanger

Partner, Pillsbury, Winthrop, Shaw, and Pittman, LLP

Charles Cangro

Principal, Personal Financial Services, Ernst & Young

Mitchell D. Eichen, J.D., LL.M.

Founder and Chief Executive Officer, Acertus Capital Management
Founder and Chief Executive Officer, The MDE Group

Allan M. Green, MD, PhD, JD

Allan M. Green Esq., LLC

Christopher Johnson

President and Managing Officer, Rackson Corporation

Bonnie Englebardt Lautenberg

Photographer, Writer

Elise Gelman Lefkowitz

Philanthropist

Philip Lovett

Founding Partner, Millennium Partners

Emilio Matt

Business Development Director, Microsoft Corporation

Julie Medler

Managing Director, Golden Seeds

Pamela J. Newman, Ph.D.

President and Chief Executive Officer, The Newman Team, Aon Corporation

Phebe Farrow Port

Senior Vice President, Global Management Strategies and Chief of Staff, Executive Management Initiatives, The Estée Lauder Companies Inc.

John H. Scully, CIMA

Senior Vice President, Global Private Client Group, Nuveen Investments

Mary Rose Taylor

Strategic Advisor, Emory ADRC

Stephen Toma

Managing Director, VJMS, LLC

Wendy L. Wilshin

Founder and Principal, WLW Designs

Alison Zaino

Philanthropist

Linda S. Zambelli

Managing Director, U.S. Trust, Bank of America Private Wealth Management